HEADER TRANSFERASE 10-APR-08 2ZM3 TITLE COMPLEX STRUCTURE OF INSULIN-LIKE GROWTH FACTOR RECEPTOR AND TITLE 2 ISOQUINOLINEDIONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 981-1286, IGF-1R KINASE DOMAIN; COMPND 5 SYNONYM: INSULIN-LIKE GROWTH FACTOR I RECEPTOR, IGF-I RECEPTOR, CD221 COMPND 6 ANTIGEN; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGF1R; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS IGFR, PROTEIN-INHIBITOR COMPLEX, TYROSINE KINASE, ATP-BINDING, KEYWDS 2 CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE MUTATION, GLYCOPROTEIN, KEYWDS 3 MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, POLYMORPHISM, KEYWDS 4 RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR W.XU,S.C.MAYER,F.BOSCHELLI,M.JOHNSON,B.DWYER REVDAT 6 15-NOV-23 2ZM3 1 REMARK REVDAT 5 01-NOV-23 2ZM3 1 REMARK SEQADV LINK REVDAT 4 09-JUN-09 2ZM3 1 REVDAT REVDAT 3 24-FEB-09 2ZM3 1 VERSN REVDAT 2 24-JUN-08 2ZM3 1 JRNL REVDAT 1 10-JUN-08 2ZM3 0 JRNL AUTH S.C.MAYER,A.L.BANKER,F.BOSCHELLI,L.DI,M.JOHNSON,C.H.KENNY, JRNL AUTH 2 G.KRISHNAMURTHY,K.KUTTERER,F.MOY,S.PETUSKY,M.RAVI,D.TKACH, JRNL AUTH 3 H.R.TSOU,W.XU JRNL TITL LEAD IDENTIFICATION TO GENERATE ISOQUINOLINEDIONE INHIBITORS JRNL TITL 2 OF INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) FOR JRNL TITL 3 POTENTIAL USE IN CANCER TREATMENT JRNL REF BIOORG.MED.CHEM.LETT. V. 18 3641 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18501599 JRNL DOI 10.1016/J.BMCL.2008.04.044 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.37 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 49126 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2480 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 NULL REMARK 3 ANGLE : 0.829 NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ZM3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000028143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JAN-04 REMARK 200 TEMPERATURE (KELVIN) : 143 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60396 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.46200 REMARK 200 R SYM FOR SHELL (I) : 0.46200 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1JQH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, PH8, 2M NACL, 13-16% REMARK 280 PEG6K, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 68.86250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 67.98100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 68.86250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 67.98100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 102410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -91.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 -33.35712 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 67.98100 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 -78.74562 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 33.35712 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 67.98100 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 78.74562 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 35.50538 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 -78.74562 REMARK 350 BIOMT1 4 -1.000000 0.000000 0.000000 -35.50538 REMARK 350 BIOMT2 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 78.74562 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 5 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 6 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 376 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 979 REMARK 465 MET A 1098 REMARK 465 GLU A 1099 REMARK 465 ASN A 1100 REMARK 465 LYS A 1286 REMARK 465 GLY B 979 REMARK 465 MET B 1098 REMARK 465 GLU B 1099 REMARK 465 ASN B 1100 REMARK 465 ASN B 1101 REMARK 465 PRO B 1102 REMARK 465 VAL B 1103 REMARK 465 LEU B 1104 REMARK 465 LYS B 1286 REMARK 465 GLY C 979 REMARK 465 GLU C 1097 REMARK 465 MET C 1098 REMARK 465 GLU C 1099 REMARK 465 ASN C 1100 REMARK 465 ASN C 1101 REMARK 465 PRO C 1102 REMARK 465 VAL C 1103 REMARK 465 LYS C 1286 REMARK 465 GLY D 979 REMARK 465 GLU D 1097 REMARK 465 MET D 1098 REMARK 465 GLU D 1099 REMARK 465 ASN D 1100 REMARK 465 ASN D 1101 REMARK 465 PRO D 1102 REMARK 465 VAL D 1103 REMARK 465 LEU D 1104 REMARK 465 ALA D 1105 REMARK 465 PRO D 1106 REMARK 465 LYS D 1286 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PTR A1161 P O1P O2P O3P REMARK 470 PTR B1161 P O1P O2P O3P REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU B 1162 N ASP B 1164 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A1024 -0.46 74.61 REMARK 500 ALA A1038 50.35 -90.81 REMARK 500 PRO A1096 10.05 -67.75 REMARK 500 ARG A1134 -5.62 77.45 REMARK 500 ASP A1135 35.81 -147.57 REMARK 500 GLU A1162 -36.83 95.24 REMARK 500 ARG B1134 -5.90 75.80 REMARK 500 ASP B1135 36.05 -141.76 REMARK 500 THR B1163 -60.15 57.60 REMARK 500 ASP B1164 5.98 85.81 REMARK 500 ALA B1209 49.76 72.73 REMARK 500 PRO C 989 20.67 -67.49 REMARK 500 ASP C 990 -40.20 52.46 REMARK 500 SER C1002 -125.01 -147.51 REMARK 500 ASP C1024 -37.63 85.64 REMARK 500 PRO C1026 -79.70 -52.79 REMARK 500 ASN C1036 -6.28 -48.81 REMARK 500 GLU C1037 -34.95 79.31 REMARK 500 ARG C1134 -4.52 69.01 REMARK 500 ASP C1135 31.85 -141.09 REMARK 500 THR C1163 -41.88 153.22 REMARK 500 LEU C1173 38.41 -140.21 REMARK 500 SER D1002 -62.85 -130.51 REMARK 500 GLN D1073 -127.08 18.69 REMARK 500 ARG D1134 -10.43 76.32 REMARK 500 PHE D1147 0.49 80.85 REMARK 500 GLU D1162 -3.45 79.04 REMARK 500 THR D1163 -45.47 -138.16 REMARK 500 LYS D1171 117.83 -179.13 REMARK 500 ALA D1209 41.66 73.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 575 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 575 D 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 575 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 575 C 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JQH RELATED DB: PDB DBREF 2ZM3 A 981 1286 UNP P08069 IGF1R_HUMAN 981 1286 DBREF 2ZM3 B 981 1286 UNP P08069 IGF1R_HUMAN 981 1286 DBREF 2ZM3 C 981 1286 UNP P08069 IGF1R_HUMAN 981 1286 DBREF 2ZM3 D 981 1286 UNP P08069 IGF1R_HUMAN 981 1286 SEQADV 2ZM3 GLY A 979 UNP P08069 EXPRESSION TAG SEQADV 2ZM3 SER A 980 UNP P08069 EXPRESSION TAG SEQADV 2ZM3 GLY B 979 UNP P08069 EXPRESSION TAG SEQADV 2ZM3 SER B 980 UNP P08069 EXPRESSION TAG SEQADV 2ZM3 GLY C 979 UNP P08069 EXPRESSION TAG SEQADV 2ZM3 SER C 980 UNP P08069 EXPRESSION TAG SEQADV 2ZM3 GLY D 979 UNP P08069 EXPRESSION TAG SEQADV 2ZM3 SER D 980 UNP P08069 EXPRESSION TAG SEQRES 1 A 308 GLY SER PHE SER ALA ALA ASP VAL TYR VAL PRO ASP GLU SEQRES 2 A 308 TRP GLU VAL ALA ARG GLU LYS ILE THR MET SER ARG GLU SEQRES 3 A 308 LEU GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY VAL SEQRES 4 A 308 ALA LYS GLY VAL VAL LYS ASP GLU PRO GLU THR ARG VAL SEQRES 5 A 308 ALA ILE LYS THR VAL ASN GLU ALA ALA SER MET ARG GLU SEQRES 6 A 308 ARG ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLU SEQRES 7 A 308 PHE ASN CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SEQRES 8 A 308 SER GLN GLY GLN PRO THR LEU VAL ILE MET GLU LEU MET SEQRES 9 A 308 THR ARG GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG SEQRES 10 A 308 PRO GLU MET GLU ASN ASN PRO VAL LEU ALA PRO PRO SER SEQRES 11 A 308 LEU SER LYS MET ILE GLN MET ALA GLY GLU ILE ALA ASP SEQRES 12 A 308 GLY MET ALA TYR LEU ASN ALA ASN LYS PHE VAL HIS ARG SEQRES 13 A 308 ASP LEU ALA ALA ARG ASN CYS MET VAL ALA GLU ASP PHE SEQRES 14 A 308 THR VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE SEQRES 15 A 308 PTR GLU THR ASP PTR PTR ARG LYS GLY GLY LYS GLY LEU SEQRES 16 A 308 LEU PRO VAL ARG TRP MET SER PRO GLU SER LEU LYS ASP SEQRES 17 A 308 GLY VAL PHE THR THR TYR SER ASP VAL TRP SER PHE GLY SEQRES 18 A 308 VAL VAL LEU TRP GLU ILE ALA THR LEU ALA GLU GLN PRO SEQRES 19 A 308 TYR GLN GLY LEU SER ASN GLU GLN VAL LEU ARG PHE VAL SEQRES 20 A 308 MET GLU GLY GLY LEU LEU ASP LYS PRO ASP ASN CYS PRO SEQRES 21 A 308 ASP MET LEU PHE GLU LEU MET ARG MET CYS TRP GLN TYR SEQRES 22 A 308 ASN PRO LYS MET ARG PRO SER PHE LEU GLU ILE ILE SER SEQRES 23 A 308 SER ILE LYS GLU GLU MET GLU PRO GLY PHE ARG GLU VAL SEQRES 24 A 308 SER PHE TYR TYR SER GLU GLU ASN LYS SEQRES 1 B 308 GLY SER PHE SER ALA ALA ASP VAL TYR VAL PRO ASP GLU SEQRES 2 B 308 TRP GLU VAL ALA ARG GLU LYS ILE THR MET SER ARG GLU SEQRES 3 B 308 LEU GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY VAL SEQRES 4 B 308 ALA LYS GLY VAL VAL LYS ASP GLU PRO GLU THR ARG VAL SEQRES 5 B 308 ALA ILE LYS THR VAL ASN GLU ALA ALA SER MET ARG GLU SEQRES 6 B 308 ARG ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLU SEQRES 7 B 308 PHE ASN CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SEQRES 8 B 308 SER GLN GLY GLN PRO THR LEU VAL ILE MET GLU LEU MET SEQRES 9 B 308 THR ARG GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG SEQRES 10 B 308 PRO GLU MET GLU ASN ASN PRO VAL LEU ALA PRO PRO SER SEQRES 11 B 308 LEU SER LYS MET ILE GLN MET ALA GLY GLU ILE ALA ASP SEQRES 12 B 308 GLY MET ALA TYR LEU ASN ALA ASN LYS PHE VAL HIS ARG SEQRES 13 B 308 ASP LEU ALA ALA ARG ASN CYS MET VAL ALA GLU ASP PHE SEQRES 14 B 308 THR VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE SEQRES 15 B 308 PTR GLU THR ASP PTR PTR ARG LYS GLY GLY LYS GLY LEU SEQRES 16 B 308 LEU PRO VAL ARG TRP MET SER PRO GLU SER LEU LYS ASP SEQRES 17 B 308 GLY VAL PHE THR THR TYR SER ASP VAL TRP SER PHE GLY SEQRES 18 B 308 VAL VAL LEU TRP GLU ILE ALA THR LEU ALA GLU GLN PRO SEQRES 19 B 308 TYR GLN GLY LEU SER ASN GLU GLN VAL LEU ARG PHE VAL SEQRES 20 B 308 MET GLU GLY GLY LEU LEU ASP LYS PRO ASP ASN CYS PRO SEQRES 21 B 308 ASP MET LEU PHE GLU LEU MET ARG MET CYS TRP GLN TYR SEQRES 22 B 308 ASN PRO LYS MET ARG PRO SER PHE LEU GLU ILE ILE SER SEQRES 23 B 308 SER ILE LYS GLU GLU MET GLU PRO GLY PHE ARG GLU VAL SEQRES 24 B 308 SER PHE TYR TYR SER GLU GLU ASN LYS SEQRES 1 C 308 GLY SER PHE SER ALA ALA ASP VAL TYR VAL PRO ASP GLU SEQRES 2 C 308 TRP GLU VAL ALA ARG GLU LYS ILE THR MET SER ARG GLU SEQRES 3 C 308 LEU GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY VAL SEQRES 4 C 308 ALA LYS GLY VAL VAL LYS ASP GLU PRO GLU THR ARG VAL SEQRES 5 C 308 ALA ILE LYS THR VAL ASN GLU ALA ALA SER MET ARG GLU SEQRES 6 C 308 ARG ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLU SEQRES 7 C 308 PHE ASN CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SEQRES 8 C 308 SER GLN GLY GLN PRO THR LEU VAL ILE MET GLU LEU MET SEQRES 9 C 308 THR ARG GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG SEQRES 10 C 308 PRO GLU MET GLU ASN ASN PRO VAL LEU ALA PRO PRO SER SEQRES 11 C 308 LEU SER LYS MET ILE GLN MET ALA GLY GLU ILE ALA ASP SEQRES 12 C 308 GLY MET ALA TYR LEU ASN ALA ASN LYS PHE VAL HIS ARG SEQRES 13 C 308 ASP LEU ALA ALA ARG ASN CYS MET VAL ALA GLU ASP PHE SEQRES 14 C 308 THR VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE SEQRES 15 C 308 PTR GLU THR ASP PTR PTR ARG LYS GLY GLY LYS GLY LEU SEQRES 16 C 308 LEU PRO VAL ARG TRP MET SER PRO GLU SER LEU LYS ASP SEQRES 17 C 308 GLY VAL PHE THR THR TYR SER ASP VAL TRP SER PHE GLY SEQRES 18 C 308 VAL VAL LEU TRP GLU ILE ALA THR LEU ALA GLU GLN PRO SEQRES 19 C 308 TYR GLN GLY LEU SER ASN GLU GLN VAL LEU ARG PHE VAL SEQRES 20 C 308 MET GLU GLY GLY LEU LEU ASP LYS PRO ASP ASN CYS PRO SEQRES 21 C 308 ASP MET LEU PHE GLU LEU MET ARG MET CYS TRP GLN TYR SEQRES 22 C 308 ASN PRO LYS MET ARG PRO SER PHE LEU GLU ILE ILE SER SEQRES 23 C 308 SER ILE LYS GLU GLU MET GLU PRO GLY PHE ARG GLU VAL SEQRES 24 C 308 SER PHE TYR TYR SER GLU GLU ASN LYS SEQRES 1 D 308 GLY SER PHE SER ALA ALA ASP VAL TYR VAL PRO ASP GLU SEQRES 2 D 308 TRP GLU VAL ALA ARG GLU LYS ILE THR MET SER ARG GLU SEQRES 3 D 308 LEU GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY VAL SEQRES 4 D 308 ALA LYS GLY VAL VAL LYS ASP GLU PRO GLU THR ARG VAL SEQRES 5 D 308 ALA ILE LYS THR VAL ASN GLU ALA ALA SER MET ARG GLU SEQRES 6 D 308 ARG ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLU SEQRES 7 D 308 PHE ASN CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SEQRES 8 D 308 SER GLN GLY GLN PRO THR LEU VAL ILE MET GLU LEU MET SEQRES 9 D 308 THR ARG GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG SEQRES 10 D 308 PRO GLU MET GLU ASN ASN PRO VAL LEU ALA PRO PRO SER SEQRES 11 D 308 LEU SER LYS MET ILE GLN MET ALA GLY GLU ILE ALA ASP SEQRES 12 D 308 GLY MET ALA TYR LEU ASN ALA ASN LYS PHE VAL HIS ARG SEQRES 13 D 308 ASP LEU ALA ALA ARG ASN CYS MET VAL ALA GLU ASP PHE SEQRES 14 D 308 THR VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE SEQRES 15 D 308 PTR GLU THR ASP PTR PTR ARG LYS GLY GLY LYS GLY LEU SEQRES 16 D 308 LEU PRO VAL ARG TRP MET SER PRO GLU SER LEU LYS ASP SEQRES 17 D 308 GLY VAL PHE THR THR TYR SER ASP VAL TRP SER PHE GLY SEQRES 18 D 308 VAL VAL LEU TRP GLU ILE ALA THR LEU ALA GLU GLN PRO SEQRES 19 D 308 TYR GLN GLY LEU SER ASN GLU GLN VAL LEU ARG PHE VAL SEQRES 20 D 308 MET GLU GLY GLY LEU LEU ASP LYS PRO ASP ASN CYS PRO SEQRES 21 D 308 ASP MET LEU PHE GLU LEU MET ARG MET CYS TRP GLN TYR SEQRES 22 D 308 ASN PRO LYS MET ARG PRO SER PHE LEU GLU ILE ILE SER SEQRES 23 D 308 SER ILE LYS GLU GLU MET GLU PRO GLY PHE ARG GLU VAL SEQRES 24 D 308 SER PHE TYR TYR SER GLU GLU ASN LYS MODRES 2ZM3 PTR A 1161 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR A 1165 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR A 1166 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR B 1161 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR B 1165 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR B 1166 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR C 1161 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR C 1165 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR C 1166 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR D 1161 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR D 1165 TYR O-PHOSPHOTYROSINE MODRES 2ZM3 PTR D 1166 TYR O-PHOSPHOTYROSINE HET PTR A1161 12 HET PTR A1165 16 HET PTR A1166 16 HET PTR B1161 12 HET PTR B1165 16 HET PTR B1166 16 HET PTR C1161 16 HET PTR C1165 16 HET PTR C1166 16 HET PTR D1161 16 HET PTR D1165 16 HET PTR D1166 16 HET 575 A 1 27 HET 575 B 1 27 HET 575 C 1 27 HET 575 D 1 27 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 575 (4Z)-6-BROMO-4-({[4-(PYRROLIDIN-1-YLMETHYL) HETNAM 2 575 PHENYL]AMINO}METHYLIDENE)ISOQUINOLINE-1,3(2H,4H)-DIONE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 12(C9 H12 N O6 P) FORMUL 5 575 4(C21 H20 BR N3 O2) FORMUL 9 HOH *457(H2 O) HELIX 1 1 SER A 982 VAL A 986 5 5 HELIX 2 2 ALA A 995 GLU A 997 5 3 HELIX 3 3 SER A 1040 PHE A 1057 1 18 HELIX 4 4 ASP A 1086 SER A 1093 1 8 HELIX 5 5 SER A 1108 ASN A 1129 1 22 HELIX 6 6 ALA A 1137 ARG A 1139 5 3 HELIX 7 7 PRO A 1175 MET A 1179 5 5 HELIX 8 8 SER A 1180 GLY A 1187 1 8 HELIX 9 9 THR A 1190 THR A 1207 1 18 HELIX 10 10 SER A 1217 GLU A 1227 1 11 HELIX 11 11 PRO A 1238 TRP A 1249 1 12 HELIX 12 12 ASN A 1252 ARG A 1256 5 5 HELIX 13 13 SER A 1258 LYS A 1267 1 10 HELIX 14 14 GLU A 1268 MET A 1270 5 3 HELIX 15 15 GLU A 1271 PRO A 1272 5 2 HELIX 16 16 GLY A 1273 SER A 1278 1 6 HELIX 17 17 SER B 982 VAL B 986 5 5 HELIX 18 18 PRO B 989 GLU B 993 5 5 HELIX 19 19 ALA B 995 GLU B 997 5 3 HELIX 20 20 SER B 1040 LYS B 1055 1 16 HELIX 21 21 ASP B 1086 LEU B 1094 1 9 HELIX 22 22 SER B 1108 ASN B 1129 1 22 HELIX 23 23 ALA B 1137 ARG B 1139 5 3 HELIX 24 24 PRO B 1175 MET B 1179 5 5 HELIX 25 25 SER B 1180 GLY B 1187 1 8 HELIX 26 26 THR B 1190 THR B 1207 1 18 HELIX 27 27 SER B 1217 GLU B 1227 1 11 HELIX 28 28 PRO B 1238 TRP B 1249 1 12 HELIX 29 29 ASN B 1252 ARG B 1256 5 5 HELIX 30 30 SER B 1258 LYS B 1267 1 10 HELIX 31 31 GLU B 1268 MET B 1270 5 3 HELIX 32 32 GLU B 1271 PRO B 1272 5 2 HELIX 33 33 GLY B 1273 SER B 1278 1 6 HELIX 34 34 SER C 982 TYR C 987 1 6 HELIX 35 35 ALA C 995 GLU C 997 5 3 HELIX 36 36 SER C 1040 LYS C 1055 1 16 HELIX 37 37 ASP C 1086 LEU C 1094 1 9 HELIX 38 38 SER C 1108 ASN C 1129 1 22 HELIX 39 39 ALA C 1137 ARG C 1139 5 3 HELIX 40 40 PRO C 1175 MET C 1179 5 5 HELIX 41 41 SER C 1180 GLY C 1187 1 8 HELIX 42 42 THR C 1190 THR C 1207 1 18 HELIX 43 43 SER C 1217 GLU C 1227 1 11 HELIX 44 44 PRO C 1238 TRP C 1249 1 12 HELIX 45 45 ASN C 1252 ARG C 1256 5 5 HELIX 46 46 SER C 1258 SER C 1265 1 8 HELIX 47 47 ILE C 1266 MET C 1270 5 5 HELIX 48 48 GLU C 1271 PRO C 1272 5 2 HELIX 49 49 GLY C 1273 SER C 1278 1 6 HELIX 50 50 SER D 982 VAL D 986 5 5 HELIX 51 51 PRO D 989 GLU D 993 5 5 HELIX 52 52 ALA D 995 GLU D 997 5 3 HELIX 53 53 SER D 1040 GLU D 1056 1 17 HELIX 54 54 ASP D 1086 LEU D 1094 1 9 HELIX 55 55 SER D 1108 ASN D 1129 1 22 HELIX 56 56 ALA D 1137 ARG D 1139 5 3 HELIX 57 57 PRO D 1175 MET D 1179 5 5 HELIX 58 58 SER D 1180 GLY D 1187 1 8 HELIX 59 59 THR D 1190 THR D 1207 1 18 HELIX 60 60 SER D 1217 GLU D 1227 1 11 HELIX 61 61 PRO D 1238 TRP D 1249 1 12 HELIX 62 62 ASN D 1252 ARG D 1256 5 5 HELIX 63 63 SER D 1258 LYS D 1267 1 10 HELIX 64 64 GLU D 1268 MET D 1270 5 3 HELIX 65 65 GLU D 1271 PRO D 1272 5 2 HELIX 66 66 GLY D 1273 SER D 1278 1 6 SHEET 1 A 5 ILE A 999 GLN A1007 0 SHEET 2 A 5 MET A1012 VAL A1022 -1 O VAL A1013 N LEU A1005 SHEET 3 A 5 GLU A1025 VAL A1035 -1 O ILE A1032 N TYR A1014 SHEET 4 A 5 THR A1075 GLU A1080 -1 O MET A1079 N ALA A1031 SHEET 5 A 5 LEU A1065 VAL A1069 -1 N LEU A1066 O ILE A1078 SHEET 1 B 2 PHE A1131 VAL A1132 0 SHEET 2 B 2 ARG A1158 ASP A1159 -1 O ARG A1158 N VAL A1132 SHEET 1 C 2 CYS A1141 VAL A1143 0 SHEET 2 C 2 VAL A1149 ILE A1151 -1 O LYS A1150 N MET A1142 SHEET 1 D 2 PTR A1166 ARG A1167 0 SHEET 2 D 2 VAL A1188 PHE A1189 -1 O PHE A1189 N PTR A1166 SHEET 1 E 5 ILE B 999 GLN B1007 0 SHEET 2 E 5 MET B1012 VAL B1022 -1 O GLU B1015 N ARG B1003 SHEET 3 E 5 GLU B1025 VAL B1035 -1 O VAL B1030 N GLY B1016 SHEET 4 E 5 THR B1075 GLU B1080 -1 O MET B1079 N ALA B1031 SHEET 5 E 5 LEU B1065 VAL B1069 -1 N GLY B1067 O ILE B1078 SHEET 1 F 2 PHE B1131 VAL B1132 0 SHEET 2 F 2 ARG B1158 ASP B1159 -1 O ARG B1158 N VAL B1132 SHEET 1 G 2 CYS B1141 VAL B1143 0 SHEET 2 G 2 VAL B1149 ILE B1151 -1 O LYS B1150 N MET B1142 SHEET 1 H 2 PTR B1166 ARG B1167 0 SHEET 2 H 2 VAL B1188 PHE B1189 -1 O PHE B1189 N PTR B1166 SHEET 1 I 5 ILE C 999 GLN C1007 0 SHEET 2 I 5 MET C1012 LYS C1019 -1 O VAL C1013 N GLY C1006 SHEET 3 I 5 GLU C1027 THR C1034 -1 O ILE C1032 N TYR C1014 SHEET 4 I 5 LEU C1076 GLU C1080 -1 O MET C1079 N ALA C1031 SHEET 5 I 5 LEU C1065 VAL C1069 -1 N LEU C1066 O ILE C1078 SHEET 1 J 2 PHE C1131 VAL C1132 0 SHEET 2 J 2 ARG C1158 ASP C1159 -1 O ARG C1158 N VAL C1132 SHEET 1 K 2 CYS C1141 VAL C1143 0 SHEET 2 K 2 VAL C1149 ILE C1151 -1 O LYS C1150 N MET C1142 SHEET 1 L 2 PTR C1166 ARG C1167 0 SHEET 2 L 2 VAL C1188 PHE C1189 -1 O PHE C1189 N PTR C1166 SHEET 1 M 5 ILE D 999 GLN D1007 0 SHEET 2 M 5 MET D1012 LYS D1019 -1 O VAL D1013 N LEU D1005 SHEET 3 M 5 GLU D1027 VAL D1035 -1 O ILE D1032 N TYR D1014 SHEET 4 M 5 THR D1075 GLU D1080 -1 O MET D1079 N ALA D1031 SHEET 5 M 5 LEU D1065 VAL D1069 -1 N LEU D1066 O ILE D1078 SHEET 1 N 2 PHE D1131 VAL D1132 0 SHEET 2 N 2 ARG D1158 ASP D1159 -1 O ARG D1158 N VAL D1132 SHEET 1 O 2 CYS D1141 VAL D1143 0 SHEET 2 O 2 VAL D1149 ILE D1151 -1 O LYS D1150 N MET D1142 SHEET 1 P 2 PTR D1166 ARG D1167 0 SHEET 2 P 2 VAL D1188 PHE D1189 -1 O PHE D1189 N PTR D1166 LINK C ILE A1160 N PTR A1161 1555 1555 1.32 LINK C PTR A1161 N GLU A1162 1555 1555 1.33 LINK C ASP A1164 N PTR A1165 1555 1555 1.33 LINK C PTR A1165 N PTR A1166 1555 1555 1.33 LINK C PTR A1166 N ARG A1167 1555 1555 1.33 LINK C ILE B1160 N PTR B1161 1555 1555 1.33 LINK C PTR B1161 N GLU B1162 1555 1555 1.32 LINK C ASP B1164 N PTR B1165 1555 1555 1.32 LINK C PTR B1165 N PTR B1166 1555 1555 1.32 LINK C PTR B1166 N ARG B1167 1555 1555 1.33 LINK C ILE C1160 N PTR C1161 1555 1555 1.33 LINK C PTR C1161 N GLU C1162 1555 1555 1.33 LINK C ASP C1164 N PTR C1165 1555 1555 1.33 LINK C PTR C1165 N PTR C1166 1555 1555 1.33 LINK C PTR C1166 N ARG C1167 1555 1555 1.33 LINK C ILE D1160 N PTR D1161 1555 1555 1.33 LINK C PTR D1161 N GLU D1162 1555 1555 1.33 LINK C ASP D1164 N PTR D1165 1555 1555 1.33 LINK C PTR D1165 N PTR D1166 1555 1555 1.33 LINK C PTR D1166 N ARG D1167 1555 1555 1.33 CISPEP 1 GLN A 1073 PRO A 1074 0 5.94 CISPEP 2 GLN B 1073 PRO B 1074 0 -0.98 SITE 1 AC1 9 LEU A1005 GLN A1007 ALA A1031 MET A1079 SITE 2 AC1 9 GLU A1080 LEU A1081 MET A1082 THR A1083 SITE 3 AC1 9 MET A1142 SITE 1 AC2 9 LEU D1005 GLN D1007 ALA D1031 MET D1079 SITE 2 AC2 9 GLU D1080 LEU D1081 MET D1082 THR D1083 SITE 3 AC2 9 MET D1142 SITE 1 AC3 9 LEU B1005 ALA B1031 LYS B1033 MET B1079 SITE 2 AC3 9 GLU B1080 LEU B1081 MET B1082 THR B1083 SITE 3 AC3 9 MET B1142 SITE 1 AC4 9 LEU C1005 GLN C1007 ALA C1031 MET C1079 SITE 2 AC4 9 GLU C1080 LEU C1081 MET C1082 THR C1083 SITE 3 AC4 9 MET C1142 CRYST1 137.725 135.962 86.380 90.00 114.27 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007261 0.000000 0.003274 0.00000 SCALE2 0.000000 0.007355 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012699 0.00000